Printer Friendly Version

Send to a Friend

Human Genome Sciences (HGS) is nearing completion of its $250-million manufacturing facility in Rockville, Md. Sited on ten acres on the Belward Research Campus of Johns Hopkins University near HGS' existing headquarters, the 290,000-sf facility will enable HGS to produce several different biotech drugs on a commercial scale including human proteins, antibodies, and fusion proteins created by the joining of two genes. Construction is expected to reach completion by year-end 2005 with validation of the facility to follow in 2006.